AzTrials
AzTrials

Cardiac DiseaseSTEPPERNCT04699136

Cardiovascular Rehabilitation and Reeducation (CVRR) in Patients With Cardiac Pathologies and the 6-minute Stepper Test

A study testing 6 minutes step test (ST6) in people with Cardiac Disease, run by Lille Catholic University at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective is to study the validity of the 6-minute stepper test (ST6) in order to determine tolerance to effort in cardiovascular patients Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Disease
What is being tested?
6 minutes step test (ST6)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteFrance
Study dates
13 Jan 2021to 28 Apr 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 18 years old,
  • Patient with a cardiac pathology (coronary bypass, valve replacement, heart transplant, coronary angioplasty),
  • Registered in Cardiovascular Rehabilitation at the Mitterie Clinic,
  • Number of rehabilitation sessions at least equal to 30,
  • Ejection fraction ≥ 45%,
  • Signed written consent of the patient,
  • Affiliation to a social security scheme.

Who cannot join

  • Cardiac decompensation,
  • Severe functional limitation,
  • Unstable acute coronary syndrome,
  • Decompensated heart failure,
  • Severe ventricular rhythm disorders,
  • Presence of an intracardiac thrombus with high embolic risk,
Show all 15Show fewer
  • Presence of a medium to large pericardial effusion (effusion of more than 10mm circumferential or 14mm localized on ultrasound),
  • Recent history (months prior to inclusion) of thrombophlebitis with or without pulmonary embolism,
  • Severe and/or symptomatic left ventricular ejection obstruction,
  • Any progressive inflammatory and/or infectious disease,
  • Severe pulmonary arterial hypertension,
  • Oxygen therapy,
  • Musculoskeletal or balance problems that would limit the ability to do any of the following the fiscal year.
  • Pregnant or breastfeeding women,
  • Incapacity to consent (including persons under guardianship or curatorship)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Clinique de la Mitterie

    Lille, 59160

Other trials in France

About this study

Official title: Use and Validation of the 6-minute Stepper Test in in Patients With Cardiac Pathologies Needing Rehabilitation and Reeducation (CVRR)

The objective is to study the validity of the 6-minute stepper test (ST6) in order to determine tolerance to effort in cardiovascular patients

Read the detailed description

The 6-minute stepper test (ST6) is an test used and validated in patients with respiratory disorders (chronic obstructive pulmonary disease) in order to evaluate their tolerance to exercise. It is well tolerated and reproducible in these patients, with the advantage that it can be performed without spatial constraints.

However, this test is not yet used in cardiology. This study proposes to validate the ST6, to evaluate the exercise tolerance of patients suffering from cardiovascular pathologies.

Conditions
Cardiac Disease
Being tested
6 minutes step test (ST6)
Keywords
Cardiovascular rehabilitation, Stepper test, 6-minute
Medical subject headings
Heart Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 6 minutes step test (ST6)Other

    Performing a 6 minutes step test at different intervals and comparing with respect with the 6 minutes walk test and cardiac stress test

Study groups in NCT04699136
Study groupRoleWhat they receive
Cardiovascular diseaseExperimentalNot described
Receives: Other: 6 minutes step test (ST6)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Internal validity of the 6 minutes step test (ST6)

    The number of steps taken in 6 minutes with the ST6 will be measured twice on the first day of the cardiovascular rehabilitation and education. The second ST6 will be performed 30 minutes after the first. Internal validity will be studied by calculating the intra-class correlation coefficient (ICC) of the number of steps from the two ST6 carried out and its 95% confidence interval.

    Measured: Day 0

  2. External validity of the ST6 with respect to the 6 minutes walk test (WT6)

    The external validity with respect to the (6 minutes walk test) WT6 will be studied by calculating the Pearson correlation coefficient and its 95% confidence interval between the number of steps from the ST6 and the distance travelled in meters from the WT6.

    Measured: Day 0

Secondary outcomes (3)
  1. External validity of the ST6 with respect to the cardiac stress test

    The external validity with respect to the cardiac stress test will be studied by calculating the Pearson correlation coefficient and its 95% confidence interval between the number of steps from the ST6 and the cardiac stress test.

    Measured: Day 0

  2. External validity of the ST6 with respect to the Oxygen saturation at rest.

    The external validity with respect to the Oxygen saturation at rest will be studied by calculating the Pearson correlation coefficient and its 95% confidence interval between the number of steps from the ST6 and the Oxygen saturation at rest.

    Measured: Day 0

  3. External validity of the ST6 with respect to the heart rate at maximum effort

    The external validity with respect to the heart rate at maximum effort will be studied by calculating the Pearson correlation coefficient and its 95% confidence interval between the number of steps from the ST6 and the heart rate.

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2021
  2. Study start13 Jan 2021
  3. Primary completion28 Apr 2022
  4. Study completion28 Apr 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04699136
Sponsor's protocol ID
RC-P0087
Other IDs
2019-A02483-54
Acronym
STEPPER
Status last verified
Dec 2025
First submitted
6 Jan 2021
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Racodon M, Fabre C, Vanhove P, Vale JD, Bolpaire R, Moutailler E, Malanda F, Secq A. Validity and Reproducibility of the Six-Minute Stepper Test in Cardiac Patients. J Cardiovasc Transl Res. 2025 Aug;18(4):993-1000. doi: 10.1007/s12265-025-10624-z. Epub 2025 May 8.

    PubMed 40341471

Questions about this trial

What is this clinical trial studying?

A study testing 6 minutes step test (ST6) in people with Cardiac Disease, run by Lille Catholic University at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Internal validity of the 6 minutes step test (ST6) (time frame: Day 0). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04699136, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in